Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/13/2002EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002EP1255827A2 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents
11/13/2002EP1255764A1 Purine derivatives
11/13/2002EP1255763A2 Motilide compounds
11/13/2002EP1255762A1 Phosphororganic compounds and the use thereof
11/13/2002EP1255760A1 Clavams as protease inhibitors
11/13/2002EP1255757A1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
11/13/2002EP1255756A1 Saccharin derivatives as orally active elastase inhibitors
11/13/2002EP1255755A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/13/2002EP1255753A2 Prodigiosin-derivatives as neoplastic and anti-viral agents
11/13/2002EP1255752A2 Pyrrole substituted 2-indolinone protein kinase inhibitors
11/13/2002EP1255751A2 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b or v1b and v1a arginine-vasopressin receptors
11/13/2002EP1255750A1 INDOLE AND BENZIMIDAZOLE INHIBITORS OF FACTOR Xa
11/13/2002EP1255749A1 Tyrosine derivatives with anti-leukotriene activity
11/13/2002EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/13/2002EP1255746A1 Oxy- and amino-substituted tetrahydrofuryl derivatives with antimour activity
11/13/2002EP1255745A2 Synthesis of water soluble 9-dihydro-paclitaxel derivatives from 9-dihydro-13-acetylbaccatin iii
11/13/2002EP1255744A1 Substituted phenylamidines medicaments containing said compounds and method for production thereof
11/13/2002EP1255742A1 2-thio-4h-3,1-benzoxazin-4-one derivatives for use as enzyme inhibitors
11/13/2002EP1255740A2 Substituted arylpyrazines
11/13/2002EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002EP1255736A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp)
11/13/2002EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002EP1255733A1 Farnesyl transferase inhibitors
11/13/2002EP1255732A1 Use of vitamin d-derivatives in the treatment of osteoporosis and related bone disorders, as well as novel vitamin d3-derivatives
11/13/2002EP1255729A1 Preparation of nitrogen mustard derivatives
11/13/2002EP1255726A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/13/2002EP1255725A2 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents
11/13/2002EP1255724A1 Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament or a diagnostic reagent and medicaments containing said compounds
11/13/2002EP1255718A1 A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
11/13/2002EP1255566A2 Preparation of aqueous clear solution dosage forms with bile acids
11/13/2002EP1255565A1 Pharmaceutical preparations containing 2-pyrrolidone as the dissolving intermediary
11/13/2002EP1255564A2 Pharmaceutical composition comprising squalene epoxidase inhibitor and macrolide immunomodulator
11/13/2002EP1255559A2 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease
11/13/2002EP1255553A2 Use of trilostane and its derivatives, optionally in combination with tamoxifen or raloxifene in the treatment of estrogen-dependent cancers e.g. breast, prostate and uterus cancers
11/13/2002EP1255552A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction
11/13/2002EP1255551A1 Use of paullone derivatives for making medicines
11/13/2002EP1255550A2 Method for identifying and using a 2b adenosine receptor antagonists to mediate mammalian cell proliferation
11/13/2002EP1255549A1 Water dispersible formulation of paroxetine
11/13/2002EP1255548A1 Use of thiostrepton as an anti-mycobacterial agent
11/13/2002EP1255547A1 Controlled-release compositions containing opioid agonist and antagonist
11/13/2002EP1255546A1 Method for improving bone modeling and chondrocyte functioning in growing canines
11/13/2002EP1255545A2 L-arginine in combination with other compounds for treating cardiovascular diseases
11/13/2002EP1255544A1 Mucin synthesis inhibitors
11/13/2002EP1255543A2 Use of retinoid-type compounds as antibacterial agents
11/13/2002EP1255542A1 Substituted amino acids as neutral sphingomyelinase inhibitors
11/13/2002EP1255541A2 Pharmaceutically active aromatic guanylhydrazones
11/13/2002EP1255540A1 Ophthalmic use of alpha adrenergic blocking agents
11/13/2002EP1255539A1 Use of alpha 1a? adrenoceptor agonists with alpha 1b? and alpha 1d? antagonism for the treatment of stress urinary incontinence
11/13/2002EP1255538A2 Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
11/13/2002EP1255537A2 Farnesyl protein transferase inhibitors for treating breast cancer
11/13/2002EP1255536A2 Indolinone derivatives for modulation of c-kit tyrosine protein kinase
11/13/2002EP1255535A2 Controlled release pharmaceutical composition containing tramadol hydrochloride
11/13/2002EP1255530A2 Cosmetic or medicinal composition containing sesquiterpene lactone or the like for treating hair-growth related disorders, and preparation method
11/13/2002EP1255456A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall
11/13/2002EP1255452A2 A method for maintaining or improving the synthesis of mucins
11/13/2002EP1255449A2 Nutritional formulation containing prebiotic substances
11/13/2002EP1183250A4 Semi-synthesis of paclitaxel using dialkyldichlorosilanes
11/13/2002EP1140916B1 Heteroaryl-cyclic acetals
11/13/2002EP1140200B1 Anthraquinone anticancer drugs
11/13/2002EP1112272B1 Muscarinic agonists and antagonists
11/13/2002EP1107968B1 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
11/13/2002EP1102762B1 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
11/13/2002EP1090006A4 Alkyl ether analogs of chlorins having an n-substituted imide ring
11/13/2002EP1086092B1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE
11/13/2002EP1068199B1 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
11/13/2002EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002EP1012139B1 Azetidinone derivatives as beta-lactamase inhibitors
11/13/2002EP1005275B1 Inhibitor and preservative formulation
11/13/2002EP1001962B1 Production of avermectin compounds
11/13/2002EP0991407B9 Stabilization of acid sensitive benzimidazols with amino/cyclodextrin combinations
11/13/2002EP0977575B1 The use of alpha-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
11/13/2002EP0973760B1 Kodaistatins a, b, c and d, a process for their production and their use
11/13/2002EP0950057B1 3-pyridyl enantiomers and their use as analgesics
11/13/2002EP0949921B1 Thrombin inhibitors
11/13/2002EP0912515B1 1,4-di-substituted piperidines as muscarinic antagonists
11/13/2002EP0912167B1 Granulates of hexahydropyrazine derivatives which can be administered orally
11/13/2002EP0910366B1 Use of thiocarboxanilide derivatives for the preparation of a medicament for preventing the transmission of hiv to uninfected cells and contraceptive compositions comprising the said derivatives
11/13/2002EP0904054B1 USE OF alpha-ALKYLGLUCOSIDES AND alpha-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS
11/13/2002EP0892638B1 Liposome-based topical vitamin d formulation
11/13/2002EP0891378B1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide
11/13/2002EP0846119B1 Thienopyrimidine derivatives, their production and use as endothelin antagonists
11/13/2002EP0845001B1 5'-substituted-ribofuranosyl benzimidazoles as antiviral agents
11/13/2002EP0843672B1 One pot synthesis of 2-oxazolidinone derivatives
11/13/2002EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002EP0839037B1 Bioprotectant composition, method of use and extraction process of curcuminoids
11/13/2002EP0833631B1 Robustaflavone and derivatives thereof as antiviral agents
11/13/2002EP0788795B1 Pharmacologically active 2-mercaptobenzimidazole derivatives
11/13/2002EP0777477B1 Improved pharmaceutical formulations containing ibuprofen and codeine
11/13/2002EP0760658B1 Compounds for inhibiting osteoclast-mediated bone resorption
11/13/2002EP0748320B1 Prodrugs of morpholine tachykinin receptor antagonists
11/13/2002EP0738281B1 Peptides and their uses against psoriasis
11/13/2002EP0735863B1 Accelerated release composition containing bromocriptine
11/13/2002EP0699074B1 Thrombin inhibitors
11/13/2002EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/13/2002EP0650489B1 Rapamycin derivatives
11/13/2002EP0618807B1 A stabilized pharmaceutical formulation comprising growth hormone and histidine
11/13/2002CN1379836A Tissue products containing antiviral agents which are mild to skin
11/13/2002CN1379819A Catalytically active recombinant MEMAPSIN and methods of use thereof
1 ... 5652 5653 5654 5655 5656 5657 5658 5659 5660 5661 5662 5663 5664 5665 5666 5667 5668 5669 5670 5671 5672 ... 7860